Recombinant Human RNASET2 Protein (Human Cells, His Tag)
Price: $ 593
Price: $ 223
Size:
50μg
10μg
Quantity:
- Expression Host: HEK293 Cells
- Accession: O00584
Add to cart
For research use only. Order now, ship in 3 days
Product Details
Synonyms | Ribonuclease T2;3.1.27.-;Ribonuclease 6;RNASE6PL |
Species | Human |
Expression Host | HEK293 Cells |
Sequence | Asp25-His256 |
Accession | O00584 |
Calculated Molecular Weight | 28.2 kDa |
Observed Molecular Weight | 38-45 kDa |
Tag | C-His |
Purity | > 95 % as determined by reducing SDS-PAGE. |
Endotoxin | < 1.0 EU per μg of the protein as determined by the LAL method. |
Storage | Store at < -20°C, stable for 6 months. Please minimize freeze-thaw cycles. |
Shipping | This product is provided as liquid. It is shipped at frozen temperature with blue ice/gel packs. Upon receipt, store it immediately at < - 20°C. |
Formulation | Supplied as a 0.2 μm filtered solution of 20mM Tris-HCl, 150mM NaCl, 20% Glycerol, pH 7.5. |
Reconstitution | Not Applicable |
Background | RNASET2 (ribonuclease T2) is an enzyme which belongs to the RNase T2 family. It is highly expressed in the temporal lobe and fetal brain. RNASET2 gene is a novel member of the Rh/T2/S-glycoprotein class of extracellular ribonucleases. This protein can be inhibited by Zn2+ and Cu2+. It has ribonuclease activity, with higher activity at acidic pH and is probably involved in lysosomal degradation of ribosomal RNA. Defects in RNASET2 are the cause of leukoencephalopathy cystic without megalencephaly. An infantile-onset syndrome of cerebral leukoencephalopathy. Affected newborns develop microcephaly and neurologic abnormalities including psychomotor impairment, seizures and sensorineural hearing impairment. The brain shows multifocal white matter lesions, anterior temporal lobe subcortical cysts, pericystic abnormal myelination, ventriculomegaly and intracranial calcifications. |